CRL
Charles River Laboratories International Inc (CRL)
Healthcare • NYSE • $177.62-2.23%
- Symbol
- CRL
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Price
- $177.62
- Daily Change
- -2.23%
- Market Cap
- $8.56B
- Trailing P/E
- N/A
- Forward P/E
- 14.36
- 52W High
- $228.88
- 52W Low
- $132.58
- Analyst Target
- $209.00
- Dividend Yield
- N/A
- Beta
- 1.45
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic services; and engages in development and production of cell therapies. The Discovery and Safety Assessment segment offers in vitro and in vivo discovery services for the discovery, development, and sa…
Company websiteResearch CRL on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.